DK0751780T3 - Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder - Google Patents

Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder

Info

Publication number
DK0751780T3
DK0751780T3 DK94920784T DK94920784T DK0751780T3 DK 0751780 T3 DK0751780 T3 DK 0751780T3 DK 94920784 T DK94920784 T DK 94920784T DK 94920784 T DK94920784 T DK 94920784T DK 0751780 T3 DK0751780 T3 DK 0751780T3
Authority
DK
Denmark
Prior art keywords
methods
antigens
presented
isolating
cell lines
Prior art date
Application number
DK94920784T
Other languages
English (en)
Inventor
Steven A Porcelli
Michael B Brenner
Evan Beckman
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK0751780T3 publication Critical patent/DK0751780T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94920784T 1993-06-21 1994-06-21 Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder DK0751780T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8007293A 1993-06-21 1993-06-21
PCT/US1994/006991 WO1995000163A1 (en) 1993-06-21 1994-06-21 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods

Publications (1)

Publication Number Publication Date
DK0751780T3 true DK0751780T3 (da) 2003-10-13

Family

ID=22155084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94920784T DK0751780T3 (da) 1993-06-21 1994-06-21 Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder

Country Status (8)

Country Link
EP (1) EP0751780B1 (da)
JP (2) JPH08511939A (da)
AT (1) ATE248602T1 (da)
CA (1) CA2165786A1 (da)
DE (1) DE69433115T2 (da)
DK (1) DK0751780T3 (da)
ES (1) ES2201078T3 (da)
WO (1) WO1995000163A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
US6238676B1 (en) 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
PL181579B1 (pl) 1994-04-14 2001-08-31 Adcock Ingram Ltd Próba diagnostyczna do wykrywania i identyfikacji gatunków Mycobacterium w próbce, oczyszczony kwas mikolowy lub mieszanina kwasów mikolowych, sposób grupowego rozdzielania i oczyszczania, wydzielone przeciwcialo, koniugat mikobakteryjny i zestaw do wykrywania obecnosci gatunków Mycobacterium PL
JPH10510142A (ja) * 1994-10-13 1998-10-06 ブリガム アンド ウイミンズ ホスピタル Ｃｄ１分子によるｔ細胞に対する疎水性抗原の提示
AU720288B2 (en) * 1995-02-22 2000-05-25 Adcock Ingram Limited A method for the isolation and purification of lipid cell-wall components
CA2243235C (en) * 1996-01-17 2010-08-10 Imperial College Innovations Limited Immunotherapy using cytotoxic t lymphocytes (ctl)
WO1998039025A2 (en) 1997-03-03 1998-09-11 Adcock Ingram Limited A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease
CA2441893C (en) 2001-03-26 2015-01-20 Dana-Farber Cancer Institute, Inc. Method of attenuating reactions to skin irritants
US7253159B2 (en) 2003-04-18 2007-08-07 The Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation using CD1 antigens
WO2006060117A2 (en) 2004-11-02 2006-06-08 The Board Of Trustees Of The Leland Stanford Junior University Methods for inhibition of nkt cells
EP2047860A1 (en) * 2007-10-12 2009-04-15 Centre National De La Recherche Scientifique (Cnrs) Phamaceutical compositons comprosing actinomycete glycerol acyl derivatives antigens, their process of extractin, and their use against tuberculosis.
AU2016212777B2 (en) 2015-01-27 2021-11-18 LAVA Therapeutics N.V. Single domain antibodies targeting CD1d
BR112021005184A8 (pt) 2018-09-19 2022-08-16 Lava Therapeutics B V Imunoglobulina cd1d de dupla ação

Also Published As

Publication number Publication date
EP0751780B1 (en) 2003-09-03
DE69433115T2 (de) 2004-04-01
JP2006104206A (ja) 2006-04-20
JPH08511939A (ja) 1996-12-17
CA2165786A1 (en) 1995-01-05
ES2201078T3 (es) 2004-03-16
EP0751780A4 (en) 1997-12-10
DE69433115D1 (de) 2003-10-09
ATE248602T1 (de) 2003-09-15
WO1995000163A1 (en) 1995-01-05
EP0751780A1 (en) 1997-01-08

Similar Documents

Publication Publication Date Title
Bingham III et al. Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions
DK0941478T4 (da) Assaymetode for peptidspecifikke T-celler
ATE248602T1 (de) Verfahren zur isolierung von cda-präsentierten antigenen, cd1-präsentierte antigeneenthaltende impfstoffe und in besagten verfahren verwendbare zelllinien
ATE215992T1 (de) Isolierung fötaler erythrozyten
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
ATE207494T1 (de) Festphase nukleinsäure-isolierung
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
ATE543098T1 (de) Identifizierung und isolierung somatischer stammzellen und verwendungen davon
ES2060621T3 (es) Anticuerpos anti-sustancia fr-900506 y metodo de inmunoensayo enzimatico altamente sensible.
Buchanan et al. Activation of the cell wall degrading protease, lysin, during sexual signalling in Chlamydomonas: the enzyme is stored as an inactive, higher relative molecular mass precursor in the periplasm.
DK1144447T3 (da) Dianostisk tuberkulosetest
TR199501326A2 (tr) Otoimmün hastaliklarin immünoterapilerinde kullanilmak üzere otoantijenden üretilen yeni peptidler.
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
ES2172287T3 (es) Metodos de deteccion y tratamiento de individuos con celulas anormales que expresan los antigenos peptidicos hla-a2/tirosinasa.
DK0755517T3 (da) Fremgangsmåde til detektion af tilstedeværelse af en Mycobacterium-art og et kit og antistoffer til anvendelse i denne
NO994705L (no) Preparering av blodpröver for deteksjon av homocystein og/eller folat
WO2001049821A3 (fr) Lignees des lymphocytes t cd4 specifiques de type th1 et procede pour leur induction ex vivo
WO1996012190A3 (en) Presentation of hydrophobic antigens to t-cells by cd1 molecules
Delgado et al. Evaluation of an enzyme-linked immunosorbent assay for the detection of sheep infected and vaccinated with Brucella melitensis
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ES2308850T3 (es) Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.
Vendrell et al. In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans
Sandeman et al. Characterization of sheep antibodies involved in precipitate formation with surface antigens of Fasciola hepatica in vitro
ATE115632T1 (de) Verfahren zur in-vitro-analyse von metallinduzierten allergien.
NO953067L (no) Ekspresjon av beskyttende antigener